Capital Signal

Actinogen Medical Limited (ASX: ACW)

Sector: Health Care

Market cap: A$163M (as of 2 Nov 2026)

Development and commercialisation of new therapeutic compounds

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
27 Feb 2026SPP$4.772M$0.04—Filing ↗
10 Oct 2024Placement$11.1M$0.03—Filing ↗
4 June 2024Rights issue$3.9M——Filing ↗
29 May 2024Rights issue$8.9M——Filing ↗
7 Sept 2023Rights issue$10M——Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
25 June 2026Dr Steven GourlayEntry?% → 5.470%Filing ↗
13 Dec 2024PRECISION OPPORTUNITIES FUND LTDEntry?% → 17.09%Filing ↗
11 Oct 2024BVF Partners L.P. on its own behalf and on behalf of BVF Inc., Mark N Lampert, Biotechnology Value Fund, L.P.; and Biotechnology Value Fund II, L.P.Entry?% → 13.77%Filing ↗
30 Aug 2024BVF Partners L.P. on its own behalf and on behalf of BVF Inc., Mark N Lampert, Biotechnology Value Fund, L.P.; and Biotechnology Value Fund II, L.P.Entry?% → 13.77%Filing ↗
16 May 2024BVF Partners L.P. on its own behalf and on behalf of BVF Inc., Mark N. Lampert, BVF I GP LLC, Biotechnology Value Fund, L.P., BVF II GP LLC and Biotechnology Value Fund II, L.P.Decrease11.160% → 9.790%Filing ↗

Director trades — on-market

DateDirectorTradeSource
3 Nov 2022Dr Steven GourlayBought 750,000Filing ↗
20 May 2022Mr Geoffrey Edward Duncan BrookeBought 340,000Filing ↗
12 May 2022Dr Steven GourlayBought 2,000,000Filing ↗
24 Mar 2021Dr George MorstynBought 2,550,000Filing ↗

Cash and runway

MetricValueAs ofSource
CashA$16M30 Sept 2026Filing ↗
Runway2.6 quarters30 Sept 2026Filing ↗

Ask about ACW in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has ACW raised money in the last year, and at what discount?
  • What was ACW's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading ACW…